Semaglutide 3mg
This is the compound that changed everything. Semaglutide — the active ingredient in Ozempic and Wegovy — works by mimicking GLP-1, the hormone that tells your brain you are full. The result: food noise disappears, cravings evaporate, and you lose 15-20% of body weight without white-knuckling a diet. Once-weekly dosing.
About Semaglutide 3mg
Semaglutide has generated unprecedented research interest following landmark clinical trials demonstrating significant effects on body weight and glycemic parameters. It acts by binding GLP-1 receptors in the pancreas (enhancing glucose-dependent insulin secretion), the hypothalamus (reducing appetite via POMC/CART neuron activation), and the GI tract (slowing gastric emptying). Published research includes the STEP, SUSTAIN, and SELECT trial programs. Its approval as both Ozempic (diabetes) and Wegovy (obesity) has made it the subject of intense academic investigation into incretin biology, metabolic disease, and cardiovascular outcomes.
Full Research Monograph — 4 PubMed CitationsYou May Also Consider
Extended semaglutide supply for serious weight loss — 6mg for longer protocols. The compound behind the biggest weight loss transformation in medical history.
- Double-dose for sustained weight loss programs
- 15-20% body weight reduction documented in trials
Retatrutide 12mg
12mgThe most powerful weight loss compound ever studied — triple-receptor agonist that achieved 24% body weight loss in trials, outperforming semaglutide by hitting THREE metabolic pathways.
- Triple-action weight loss — targets GLP-1, GIP, AND glucagon receptors
- 24% body weight loss in trials — MORE than semaglutide
Cagrilintide
5mgThe semaglutide amplifier — a long-acting amylin that pairs with GLP-1 drugs to supercharge weight loss. Part of the CagriSema combination that's the next breakthrough.
- Long-acting amylin analog for appetite suppression
- Pairs with semaglutide for enhanced weight loss (CagriSema)